GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » 5-Year Yield-on-Cost %

Betta Pharmaceuticals Co (SZSE:300558) 5-Year Yield-on-Cost % : 0.29 (As of May. 04, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co 5-Year Yield-on-Cost %?

Betta Pharmaceuticals Co's yield on cost for the quarter that ended in Mar. 2025 was 0.29.


The historical rank and industry rank for Betta Pharmaceuticals Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SZSE:300558' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.07   Med: 0.27   Max: 0.62
Current: 0.29


During the past 13 years, Betta Pharmaceuticals Co's highest Yield on Cost was 0.62. The lowest was 0.07. And the median was 0.27.


SZSE:300558's 5-Year Yield-on-Cost % is ranked worse than
93.77% of 514 companies
in the Drug Manufacturers industry
Industry Median: 2.22 vs SZSE:300558: 0.29

Competitive Comparison of Betta Pharmaceuticals Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Betta Pharmaceuticals Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's 5-Year Yield-on-Cost % falls into.


;
;

Betta Pharmaceuticals Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Betta Pharmaceuticals Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Betta Pharmaceuticals Co  (SZSE:300558) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Betta Pharmaceuticals Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Betta Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 355, Xingzhong Road, Economic and Technological Development Zone, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311100
Betta Pharmaceuticals Co Ltd is a pharmaceutical enterprise that focuses on the research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates in China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co Headlines

No Headlines